Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study-Reference-Cited by-同舟云学术

Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study

Published:2023-11 Issue: Volume:65 Page:102300
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Jeon Dongsub,Cha Hye Ryeong^ORCID,Chung Sung Won^ORCID,Choi Jonggi,Lee Danbi,Shim Ju Hyun,Kim Kang Mo,Lim Young-Suk,Lee Han Chu,Lee Seung Won^ORCID,Choi Won-Mook^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories;Foreman;Lancet,2018

3. Global elimination of chronic hepatitis;Thomas;N Engl J Med,2019

4. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

5. The role of hepatic resection in the treatment of hepatocellular cancer;Roayaie;Hepatology,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanistic insights behind the anticancer effects of statins in liver cancer;Hepatology Communications;2024-09

2. Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling;Genes & Diseases;2024-09

3. AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors;Liver International;2024-07-24

4. Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns;Frontiers in Immunology;2024-07-09

5. Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma;Scientific Reports;2024-07-04